ArticleBreast cancer research : BCR2025

Correction: Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.

Ricardo Ribas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.